You can buy or sell ASMB and other stocks, options, ETFs, and crypto commission-free!
Assembly Biosciences, Inc. Common Stock, also called Assembly Biosciences, is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. Read More It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.
South San Francisco, California
52 Week High
52 Week Low
— per share
Expected May 7, After Hours